Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis

Kristian Thorlund1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada;2 Stanford Prevention Research Center, Stanford University, Stanford, CA, USA;4 Redwood Outcomes, Vancouver, BC, CanadaCorrespondence[email protected]

Ping Wu3 Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada;4 Redwood Outcomes, Vancouver, BC, Canada

Eric Druyts3 Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada;4 Redwood Outcomes, Vancouver, BC, Canada

Shawn Eapen3 Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada;4 Redwood Outcomes, Vancouver, BC, Canada

Edward J Mills2 Stanford Prevention Research Center, Stanford University, Stanford, CA, USA;3 Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada;4 Redwood Outcomes, Vancouver, BC, Canada

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date